These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34586293)

  • 21. Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.
    Martinez EZ; Aragon DC; Pontes CM; Nunes AA; Maciel ELN; Jabor P; Zandonade E
    Rev Soc Bras Med Trop; 2021; 54():e01382021. PubMed ID: 34231772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 in healthcare workers in the state of Espírito Santo, Brazil: clinical and sociodemographic characteristics associated with death and hospitalization.
    Corona RA; Cunha AAD
    Einstein (Sao Paulo); 2022; 20():eAO6241. PubMed ID: 35293527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years - Mississippi, September-November 2020.
    Hobbs CV; Martin LM; Kim SS; Kirmse BM; Haynie L; McGraw S; Byers P; Taylor KG; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1925-1929. PubMed ID: 33332298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil.
    Aguiar S; Baiocchi G; Duprat JP; Coimbra FJF; Makdissi FB; Vartanian JG; de Cassio Zequi S; Gross JL; Nakagawa S; Yazbek G; Bussolotti R; Avelino França E Silva I; Kowalski LP
    J Surg Oncol; 2020 Dec; 122(7):1293-1295. PubMed ID: 32786076
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy.
    Saeed U; Uppal SR; Piracha ZZ; Rasheed A; Aftab Z; Zaheer H; Uppal R
    Virol J; 2021 Feb; 18(1):34. PubMed ID: 33581714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Susceptibility in Bronchial Asthma.
    Green I; Merzon E; Vinker S; Golan-Cohen A; Magen E
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):684-692.e1. PubMed ID: 33242628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Shakiba M; Nazemipour M; Heidarzadeh A; Mansournia MA
    Epidemiol Infect; 2020 Nov; 148():e300. PubMed ID: 33183367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
    Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
    Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
    Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical and serological follow-up of paediatric patients infected by SARS-CoV-2.
    Calitri C; Fantone F; Benetti S; Lupica MM; Ignaccolo MG; Banino E; Viano A; Pace M; Castella A; Gaido F; Garofalo F; AslTorinoTre Study Group Paediatric Covid
    Infez Med; 2021 Jun; 29(2):216-223. PubMed ID: 34061786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Michos A; Savvidou P; Syridou G; Eleftheriou E; Iosifidis E; Grivea I; Spoulou V; Galanakis E; Syrogiannopoulos G; Tsolia M; Roilides E; Papaevangelou V
    Epidemiol Infect; 2021 Feb; 149():e70. PubMed ID: 33622430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.
    Venugopal U; Jilani N; Rabah S; Shariff MA; Jawed M; Mendez Batres A; Abubacker M; Menon S; Pillai A; Shabarek N; Kasubhai M; Dimitrov V; Menon V
    Int J Infect Dis; 2021 Jan; 102():63-69. PubMed ID: 33075539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reopening schools in the context of increasing COVID-19 community transmission: The French experience.
    Gras-Le Guen C; Cohen R; Rozenberg J; Launay E; Levy-Bruhl D; Delacourt C
    Arch Pediatr; 2021 Apr; 28(3):178-185. PubMed ID: 33618971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown.
    Breyer MK; Breyer-Kohansal R; Hartl S; Kundi M; Weseslindtner L; Stiasny K; Puchhammer-Stöckl E; Schrott A; Födinger M; Binder M; Fiedler M; Wouters EFM; Burghuber OC
    Sci Rep; 2021 May; 11(1):10158. PubMed ID: 33980950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 seroprevalence in military police force, Southern Brazil.
    Pasqualotto AC; Pereira PC; Lana DFD; Schwarzbold AV; Ribeiro MS; Riche CVW; Castro CPP; Korsack PL; Ferreira PEB; Domingues GC; Ribeiro GT; Carneiro M; Caurio CFB; Vasconcellos ICDS; Knebel LM; Zamberlan L; Stolz AP; Vilanova M; Watte G; Kalil AN
    PLoS One; 2021; 16(4):e0249672. PubMed ID: 33886596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses.
    Stringari LL; de Souza MN; de Medeiros Junior NF; Goulart JP; Giuberti C; Dietze R; Ribeiro-Rodrigues R
    PLoS One; 2021; 16(1):e0244937. PubMed ID: 33406122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
    Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.